Page 560 - Read Online

Page 10 of 10 Bieu et al. Hepatoma Res 2020;6:49 I http://dx.doi.org/10.20517/2394-5079.2020.39

liver transplantation in hepatocellular carcinoma. Liver Transpl 2006;12:1260-7.
9. De Luna W, Sze DY, Ahmed A, Ha BY, Ayoub W, et al. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy
and a bridge toward liver transplantation. Am J Transplant 2009;9:1158-68.
10. Katz AW, Chawla S, Qu Z, Kashyap R, Milano MT, et al. Stereotactic hypofractionated radiation therapy as a bridge to transplantation for
hepatocellular carcinoma: clinical outcome and pathologic correlation. Int J Radiat Oncol Biol Phys 2012;83:895-900.
11. O’Connor JK, Trotter J, Davis GL, Dempster J, Klintmalm GB, et al. Long-term outcomes of stereotactic body radiation therapy in the
treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl 2012;18:949-54.
12. Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, et al. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to
transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. J Hepatol 2017;67:92-9.
13. Paik EK, Kim MS, Jang WI, Seo YS, Cho CK, et al. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter
arterial chemoembolization in hepatocellular carcinoma. Radiat Oncol 2016;11:22.
14. Honda Y, Kimura T, Aikata H, Kobayashi T, Fukuhara T, et al. Stereotactic body radiation therapy combined with transcatheter arterial
chemoembolization for small hepatocellular carcinoma. J Gastroenterol Hepatol 2013;28:530-6.
15. Cho JY, Paik YH, Park HC, Yu JI, Sohn W, et al. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy
for advanced hepatocellular carcinoma. Liver Int 2014;34:795-801.
16. Kudo M, Ikeda M, Ueshima K, Sakamoto M, Shiina S, et al. Response evaluation criteria in cancer of the liver version 5 (RECICL 2019
revised version). Hepatol Res 2019;49:981-9.
17. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, et al. Stereotactic body radiation therapy: the report of AAPM Task Group
101. Med Phys 2010;37:4078-101.
18. Allard MA, Sebagh M, Ruiz A, Guettier C, Paule B, et al. Does pathological response after transarterial chemoembolization for
hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? J Hepatol
2015;63:83-92.
19. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, et al. Impact of pretransplantation transarterial
chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005;11:767-75.
20. She WH, Cheung TT. Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver
transplantation. Transl Gastroenterol Hepatol 2016;1:34.
21. Choi SH, Seong J. Stereotactic body radiotherapy: does it have a role in management of hepatocellular carcinoma? Yonsei Med J
2018;59:912-22.
22. Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator.
Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-70.
23. Kollmann D, Selzner N, Selzner M. Bridging to liver transplantation in HCC patients. Langenbecks Arch Surg 2017;402:863-71.
24. Sandroussi C, Dawson LA, Lee M, Guindi M, Fischer S, et al. Radiotherapy as a bridge to liver transplantation for hepatocellular
carcinoma. Transpl Int 2010;23:299-306.
25. Eriguchi T, Takeda A, Sanuki N, Oku Y, Aoki Y, et al. Acceptable toxicity after stereotactic body radiation therapy for liver tumors
adjacent to the central biliary system. Int J Radiat Oncol Biol Phys 2013;85:1006-11.
26. Moore A, Cohen-Naftaly M, Tobar A, Kundel Y, Benjaminov O, et al. Stereotactic body radiation therapy (SBRT) for definitive treatment
and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma. Radiat Oncol 2017;12:163.
27. Gresswell S, Tobillo R, Hasan S, Uemura T, Machado L, et al. Stereotactic body radiotherapy used as a bridge to liver transplant in
patients with hepatocellular carcinoma and Child-Pugh score ≥8 cirrhosis. J Radiosurg SBRT. 2018;5:261-7.
28. Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT. Treatment before liver transplantation for HCC. Ann Surg Oncol 2008;15:993-1000.
29. European Association For The Study Of The Liver., European Organisation For Research And Treatment Of Cancer. EASL-EORTC
clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43.
30. Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, et al. Efficacy of selective transarterial chemoembolization in inducing
tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology 2011;53:1580-9.
31. ClinicalTrials.gov. Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver
Transplant (SBRTvsTACE). Available from: https://clinicaltrials.gov/ct2/show/NCT02182687. [Last accessed on 24 Jul 2020].
32. ClinicalTrials.gov. Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
(SBRTvsTACE). Available from: https://clinicaltrials.gov/ct2/show/NCT03960008. [Last accessed on 24 Jul 2020].
33. Jacob R, Turley F, Redden DT, Saddekni S, Aal AK, et al. Adjuvant stereotactic body radiotherapy following transarterial
chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cm. HPB (Oxford) 2015;17:140-9.
34. Buckstein M, Kim E, Facciuto M, Sung M, Taouli B, et al. Phase II trial using combination of TACE and SBRT for unresectable single
large HCC: interim report. Int J Radiat Oncol Biol Phys 2019;105:E214-5.
35. Price TR, Perkins SM, Sandrasegaran K, Henderson MA, Maluccio MA, et al. Evaluation of response after stereotactic body radiotherapy
for hepatocellular carcinoma. Cancer 2012;118:3191-8.
36. Sanuki-Fujimoto N, Takeda A, Ohashi T, Kunieda E, Iwabuchi S, et al. CT evaluations of focal liver reactions following stereotactic body
radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function. Br J
Radiol 2010;83:1063-71.